Plans to hire 800 professionals and IPO Launch in FY 2026-27
Mumbai-headquartered Steris Healthcare with operations in Navi Mumbai, has announced a Rs 50 crore multi-pronged growth strategy, including a major expansion into South India, a doubling of production capacity, and plans to launch its Initial Public Offering (IPO) in FY 2026-27. The company, which recently crossed ₹100 crore in annual sales, aims to solidify its national presence and enhance its ability to deliver innovative, affordable healthcare solutions.
As part of its strategic expansion, Steris Healthcare will establish a state-of-the-art manufacturing facility in South India, targeting key markets in Kerala, Tamil Nadu, Hyderabad (Telangana), and Bengaluru (Karnataka). This move is designed to streamline supply chains and strengthen the company’s reach in high-demand regions.
Steris Healthcare will launch new medications and healthcare products aimed at addressing critical therapeutic needs. This initiative reflects the company’s unwavering commitment to innovation and bridging gaps in medical care. The expansion is also expected to generate 800 new jobs across manufacturing, R&D, sales, and logistics, fostering
economic growth in South India.
Jeevan Kasara, Director and CEO, Steris Healthcare, shared his vision for the company’s future, “The Rs 50 crore expansion and our upcoming IPO in FY 2026-27 mark a defining chapter in Steris’ journey. By deepening our roots in South India and investing in cutting-edge therapies, we are poised to serve millions more patients while creating long-term value for our stakeholders. Our focus remains on making healthcare accessible without compromising on innovation.”
Renuka Kasara, Director, Steris Healthcare, added, “Crossing Rs 100 crore in sales this year is a testament to our team’s dedication and the trust healthcare providers have placed in us. As we embark on this expansion phase, we remain committed to maintaining the highest standards of quality while expanding our product portfolio to serve diverse medical needs across India.”
